Psychosocial Burden of Cervical Cancer Treatment at the Joliot Curie Institute of Dakar, Senegal
American International Journal of Social Science · 01.12.2022
DOI: 10.30845/aijss.v11p2 ↗Kurz gefasst
Fachartikel in der Zeitschrift American International Journal of Social Science, online erschienen am 01.12.2022. Verfasst von Mory DIALLO und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cervical cancer is a high incidence disease in Senegal. Its management is problematic. The objective of this article is to analyze the psychosocial burden of cervical cancer patients. Patients were recruited from the Joliot Curie Institute of Dakar. Semi-structured interviews were used to address patient/caregiver communication, the relationship between caregivers and patients, and the experience of the disease within the family and the community. The results show that some patients have difficulty coping with their illness in the family and community, and others have conflicting relationships with their caregivers and hosts. This is a huge psychosocial burden for patients.
Zitieren
APA
DIALLO, M., GNING, A., DIENG, S. D., NIANG, C. I., & DEM, A. (2022). Psychosocial Burden of Cervical Cancer Treatment at the Joliot Curie Institute of Dakar, Senegal. American International Journal of Social Science. https://doi.org/10.30845/aijss.v11p2
Vancouver
DIALLO M, GNING A, DIENG SD, NIANG CI, DEM A. Psychosocial Burden of Cervical Cancer Treatment at the Joliot Curie Institute of Dakar, Senegal. American International Journal of Social Science. 2022. doi:10.30845/aijss.v11p2
BibTeX
@article{DIALLO2022,
author = {DIALLO, Mory and GNING, Abdou and DIENG, Sara Daniele and NIANG, Cheikh Ibrahima and DEM, Ahmadou},
title = {Psychosocial Burden of Cervical Cancer Treatment at the Joliot Curie Institute of Dakar, Senegal},
journal = {American International Journal of Social Science},
year = {2022},
doi = {10.30845/aijss.v11p2}
}
EUVIMED